The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1474
August 3, 2015
View Complete Issue         Table of Contents 2019 
Polidocanol (Varithena) for Varicose Veins
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Polidocanol (Varithena) for Varicose Veins
August 3, 2015 (Issue: 1474)
An injectable foam formulation of the sclerosing agent polidocanol (Varithena – Provensis/BTG) has been approved by the FDA for treatment of incompetent veins and visible varicosities of the great saphenous vein system. It is the first foam...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Polidocanol (Varithena) for Varicose Veins
Article code: 1474c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.